Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|November 20, 2024
Durlobactam to boost the clinical utility of standard of care β-lactams against <i>Mycobacterium abscessus</i> lung diseaseDereje A Negatu, Wassihun Wedajo Aragaw, Tewodros T Gebresilase, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2012
Variations of subunit {varepsilon} of the Mycobacterium tuberculosis F1Fo ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207Goran Biukovic, Sandip Basak, Malathy Sony Subramanian Manimekalai, et al.
Frontiers in Microbiology|December 20, 2018
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force DisruptionAnnanya Shetty, Zhujun Xu, Umayal Lakshmanan, et al.
The Journal of Biological Chemistry|May 11, 2010
Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-GuerinKai Leng Low, Guanghou Shui, Klaus Natter, et al.
Frontiers in Microbiology|August 4, 2018
The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular DrugsHuan Chen, Samuel A Nyantakyi, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Potency boost of a <i>Mycobacterium tuberculosis</i> dihydrofolate reductase inhibitor by multienzyme F<sub>420</sub>H<sub>2</sub>-dependent reductionWassihun Wedajo Aragaw, Brendon M Lee, Xuan Yang, et al.
The Journal of Biological Chemistry|May 13, 2017
The uniqueness of subunit α of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptationPriya Ragunathan, Hendrik Sielaff, Lavanya Sundararaman, et al.
ACS Infectious Diseases|October 10, 2017
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanDPooja Gopal, Wilson Nartey, Priya Ragunathan, et al.
Bioorganic & Medicinal Chemistry|October 13, 2022
Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agentsPooja V Hegde, Wassihun W Aragaw, Malcolm S Cole, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial ActivityUday S Ganapathy, Rubén González Del Rio, Mónica Cacho-Izquierdo, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|November 20, 2024
Durlobactam to boost the clinical utility of standard of care β-lactams against <i>Mycobacterium abscessus</i> lung diseaseDereje A Negatu, Wassihun Wedajo Aragaw, Tewodros T Gebresilase, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2012
Variations of subunit {varepsilon} of the Mycobacterium tuberculosis F1Fo ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207Goran Biukovic, Sandip Basak, Malathy Sony Subramanian Manimekalai, et al.
Frontiers in Microbiology|December 20, 2018
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force DisruptionAnnanya Shetty, Zhujun Xu, Umayal Lakshmanan, et al.
The Journal of Biological Chemistry|May 11, 2010
Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-GuerinKai Leng Low, Guanghou Shui, Klaus Natter, et al.
Frontiers in Microbiology|August 4, 2018
The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular DrugsHuan Chen, Samuel A Nyantakyi, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Potency boost of a <i>Mycobacterium tuberculosis</i> dihydrofolate reductase inhibitor by multienzyme F<sub>420</sub>H<sub>2</sub>-dependent reductionWassihun Wedajo Aragaw, Brendon M Lee, Xuan Yang, et al.
The Journal of Biological Chemistry|May 13, 2017
The uniqueness of subunit α of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptationPriya Ragunathan, Hendrik Sielaff, Lavanya Sundararaman, et al.
ACS Infectious Diseases|October 10, 2017
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanDPooja Gopal, Wilson Nartey, Priya Ragunathan, et al.
Bioorganic & Medicinal Chemistry|October 13, 2022
Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agentsPooja V Hegde, Wassihun W Aragaw, Malcolm S Cole, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial ActivityUday S Ganapathy, Rubén González Del Rio, Mónica Cacho-Izquierdo, et al.
Pageof 18